Back to search
Hypochondroplasia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hypochondroplasia trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Hypochondroplasia trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a long-term, multicenter, non-interventional study of children ages 2.5 to \<17 years with hypochondroplasia (HCH).
The purpose of this study is to evaluate the safety and efficacy of daily administration of vosoritide in participants with HCH aged 0 to \< 36 months over a 52…
The study aims to identify which Syde®-derived digital outcomes are reliable in FGFR3-related Skeletal Dysplasia. This requires to set-up a natural history stud…
This study will assess growth over time and the clinical course of HCH in children by collecting growth measurements and other variables of interest.
This registry is a observational, single-center study designed to collect clinical data on patients with achondroplasia and hypochondroplasia.
ACCEL2/3 is a Phase 2/3 study. The purpose of the Phase 2 portion of the study (ACCEL2/3) is to evaluate the efficacy and safety of infigratinib in children wit…
Phase 2, multicenter, OLE study to evaluate the long-term safety, tolerability, and efficacy of infigratinib, an FGFR (fibroblast growth factor receptor) 1-3-se…